US Patent Issued to The Regents of the University of California on April 29 for "Prevention of rosacea inflammation" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,404, issued on April 29, was assigned to The Regents of the University of California (Oakland, Calif.).

"Prevention of rosacea inflammation" was invented by Richard L. Gallo (San Diego), Anna Di Nardo (La Jolla, Calif.) and Yumiko Muto (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure demonstrates the role of mast cell stabilizers in treating rosacea. The disclosure also shows the role of mast cells, cathelicidin, serine protease and/or vitamin D3 in rosacea pathology and the use of antagonists and inhibitors thereof to treat rosacea."

The patent was filed on June 7, 2022, under Application No. 17/834,626.

*For further...